Elite Health Systems Inc. (EHSI)
OTCMKTS · Delayed Price · Currency is USD
0.9000
-0.1000 (-10.00%)
Aug 6, 2026, 12:11 PM EST
Elite Health Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.42 | 1.02 | - | - | - | 1.06 | |
Revenue Growth | - | - | - | - | - | -66.56% |
Cost of Revenue | 2.19 | 0.91 | - | - | - | 0.09 |
Gross Profit | 0.24 | 0.12 | - | - | - | 0.98 |
Selling, General & Admin | 4.95 | 3.96 | 1.79 | 0.77 | 1.07 | 1.06 |
Operating Expenses | 4.95 | 3.96 | 1.79 | 0.77 | 1.07 | 1.06 |
Operating Income | -4.71 | -3.84 | -1.79 | -0.77 | -1.07 | -0.09 |
Interest Expense | - | - | - | - | - | -0 |
Interest & Investment Income | 0.01 | 0.01 | 0.01 | - | - | 0.01 |
Earnings From Equity Investments | - | - | -0.43 | -0.05 | -0.15 | -0.47 |
Other Non Operating Income (Expenses) | - | - | - | -0 | - | - |
EBT Excluding Unusual Items | -4.7 | -3.83 | -2.22 | -0.82 | -1.22 | -0.55 |
Impairment of Goodwill | -3.98 | -3.98 | - | - | -0.32 | - |
Pretax Income | -8.67 | -7.8 | -2.22 | -0.82 | -1.53 | -0.55 |
Income Tax Expense | - | - | -0.16 | - | 0.04 | 0.42 |
Earnings From Continuing Operations | -8.67 | -7.8 | -2.06 | -0.82 | -1.57 | -0.97 |
Minority Interest in Earnings | - | - | - | - | 0.24 | 0.09 |
Net Income | -8.67 | -7.8 | -2.06 | -0.82 | -1.34 | -0.88 |
Net Income to Common | -8.67 | -7.8 | -2.06 | -0.82 | -1.34 | -0.88 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 24 | 23 | 15 | 9 | 8 | 8 |
Shares Outstanding (Diluted) | 24 | 23 | 15 | 9 | 8 | 8 |
Shares Change | 38.48% | 47.06% | 65.62% | 18.40% | 0.64% | - |
EPS (Basic) | -0.35 | -0.35 | -0.13 | -0.09 | -0.17 | -0.11 |
EPS (Diluted) | -0.35 | -0.35 | -0.13 | -0.09 | -0.17 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.91 | -2.95 | -1.52 | -0.89 | -1.41 | 0.17 |
Free Cash Flow Per Share | -0.16 | -0.13 | -0.10 | -0.10 | -0.18 | 0.02 |
Gross Margin | 9.70% | 11.52% | - | - | - | 91.89% |
Operating Margin | -194.47% | -374.90% | - | - | - | -8.29% |
Profit Margin | -358.13% | -762.11% | - | - | - | -83.03% |
Free Cash Flow Margin | -161.27% | -287.79% | - | - | - | 16.40% |
EBITDA | - | -3.83 | - | - | - | - |
D&A For EBITDA | - | 0.01 | - | - | - | - |
EBIT | -4.71 | -3.84 | -1.79 | -0.77 | -1.07 | -0.09 |
EBIT Margin | -194.47% | - | - | - | - | -8.29% |